Eyewash: Package Insert and Label Information

EYEWASH- water solution
Akorn, Inc.

Drug Facts

Active ingredient

Purified water 98.3%




For cleansing the eye to help relieve irritation or burning by removing loose foreign material


For external use only

Do not use

  • if you experience any open wounds in or near the eyes and obtain immediate medical treatment
  • if solution changes color or becomes cloudy

When using this product

  • to avoid contamination, do not touch tip of container to any surface
  • do not reuse
  • once opened, discard

Stop use and ask a doctor if you experience

  • changes in vision
  • eye pain
  • condition worsens or persists
  • continued redness or irritation of the eye

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.


Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle.

Other information

  • lot number is printed on the bottle
  • store at 20° to 25° C [68° to 77° F]
  • for your protection, this bottle has an imprinted white seal with black printing “TAMPER EVIDENT SEAL”
  • do not use if this seal is missing or broken
  • use before expiration date marked on bottle

Inactive ingredients

boric acid, sodium borate, sodium chloride


Call 888-628-0581

Principal Display Panel Text for Container Label:

Akorn logo




Purified Water, 98.3%

NDC 17478-620-04

Single Use

Distributed by:

Akorn, Inc.

Lake Forest, IL


EHAAL Rev. 08/13

Made in Canada

Sterile Solution

4 fl.oz. (118 mL)

Principal Display Panel Text for Container Label
(click image for full-size original)
water solution
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:17478-620
Route of Administration OPHTHALMIC DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
WATER (WATER) WATER 929 g in 946 mL
Inactive Ingredients
Ingredient Name Strength
# Item Code Package Description Multilevel Packaging
1 NDC:17478-620-04 1 BOTTLE in 1 BOTTLE contains a BOTTLE
1 118 mL in 1 BOTTLE This package is contained within the BOTTLE (17478-620-04)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022305 06/01/2014
Labeler — Akorn, Inc. (062649876)
Registrant — Niagara Pharmaceuticals, Inc. (205477792)
Name Address ID/FEI Operations
Niagara Pharmaceuticals, Inc. 205477792 manufacture (17478-620)

Revised: 11/2019 Akorn, Inc.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.